James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

Who else could be on the move between now and the trade deadline? We'll have the latest reports and news from our NBA insiders from around the league. MORE: Trade tracker | Trade grades | Outlook ...

Yet this is far below the government’s goal, with bureaucratic delays partly to blame. Peter Janssen reports. Paris metro operator RATP believes it can use the experience it has gained in managing the ...